Pharming Group N.V. Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2023-12-15: Form 6-K; Period of report 2023-12-13; Description 6-K; Document secondindicationpid.htm.
- 2023-11-13: Form 6-K; Period of report 2023-11-10; Description 6-K; Document emaandmhraupdate_10nov23.htm.
- 2023-10-26: Form 6-K; Period of report 2023-10-26; Description 6-K; Document pharminggroup3q2023financi.htm.
- 2023-09-25: Form 6-K; Period of report 2023-09-25; Description 6-K; Document egmresults25sep23.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2023-12-15 | 6-K | 2023-12-13 | 6-K | secondindicationpid.htm |
| 2023-11-13 | 6-K | 2023-11-10 | 6-K | emaandmhraupdate_10nov23.htm |
| 2023-10-26 | 6-K | 2023-10-26 | 6-K | pharminggroup3q2023financi.htm |
| 2023-09-25 | 6-K | 2023-09-25 | 6-K | egmresults25sep23.htm |
| 2023-08-14 | 6-K | 2023-08-14 | 6-K | egm2023.htm |
| 2023-08-09 | 6-K | 2023-08-09 | 6-K | jpclinicaltrial.htm |
| 2023-08-03 | 6-K | 2023-08-03 | 6-K | h1pr2023.htm |
| 2023-07-18 | 6-K | 2023-07-18 | 6-K | bodchair.htm |
| 2023-06-01 | 6-K | 2023-06-01 | 6-K | prv.htm |
| 2023-05-19 | 6-K | 2023-05-17 | 6-K | resultsof2023agm.htm |
| 2023-05-11 | 6-K | 2023-05-11 | 6-K | a6-kpressreleaseq12023.htm |
| 2023-04-11 | 6-K | 2023-04-11 | 6-K | firstcommercialshipmentjoe.htm |
| 2023-04-05 | 6-K | 2023-04-05 | 6-K | ar22and20-ffiling.htm |
| 2023-03-27 | 6-K | 2023-03-24 | 6-K | leniolisibapprovalfda.htm |
| 2023-03-16 | 6-K | 2023-03-16 | 6-K | pharminggroupfinancialresu.htm |
| 2023-03-13 | 6-K | 2023-03-13 | 6-K | pharminggroupannouncesthat.htm |
| 2023-03-13 | 6-K | 2023-03-12 | 6-K | pharminggroupissuesstateme.htm |
| 2023-02-21 | 6-K | 2023-02-21 | 6-K | firstpatientenrolledinpedi.htm |
| 2023-02-17 | 6-K | 2023-02-16 | 6-K | emapressreleasefebruary162.htm |